Sir John B. Gurdon and Shinya Yamanaka have won the 2012 Nobel Prize in Physiology or Medicine

Download PDF Copy

Editorial Checklist

Reviewed

Oct 8 2012

The 2012 Nobel Prize in Physiology or Medicine has been awarded jointly to Sir John B. Gurdon and Shinya Yamanaka for the discovery that mature cells can be reprogrammed to become pluripotent.

The prize was announced at the Karolinska Institutet in Stockholm, Sweden on Monday 8th October 9:30 GMT.

Medicine is traditionally the first of the Nobel prizes awarded each year. It will be followed in the coming days by announcements for prizes in Chemistry, Physics, literature, Peace and Economics.

Source:

http://www.nobelprize.org/nobel_prizes/medicine/laureates/2012/press.html

Posted in: Medical Science News

Tags: Medicine, Physiology

Comments (0)

Download PDF Copy

Suggested Reading

New diagnostic guidelines aim to distinguish common memory disorder from Alzheimer’s

New diagnostic guidelines aim to distinguish common memory disorder from Alzheimer’s

Gut microbes and plant foods: a powerful duo for healthy aging

Gut microbes and plant foods: a powerful duo for healthy aging

Gut-derived sugars: A potential game-changer for weight management and diabetes

Gut-derived sugars: A potential game-changer for weight management and diabetes

COVID-19 dramatically raises the risk of developing ME/CFS

COVID-19 dramatically raises the risk of developing ME/CFS

Fewer anesthesiology residents applying to US pain medicine fellowships

Fewer anesthesiology residents applying to US pain medicine fellowships

Microplastics may accumulate in the brain at higher levels than in the kidney or liver

Microplastics may accumulate in the brain at higher levels than in the kidney or liver

Manuka vs. Ohia Lehua honey: Study reveals key antioxidant differences and health benefits

Manuka vs. Ohia Lehua honey: Study reveals key antioxidant differences and health benefits

Does COVID increase the risk of Alzheimer’s disease?

Does COVID increase the risk of Alzheimer’s disease?

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Researchers create an atlas of health associations for GLP-1 receptor agonists